Zoledronic and Aranesp drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Zoledronic (zoledronic acid) and Aranesp (darbepoetin alfa). Common drug interactions include fatigue among females and fall among males.
The phase IV clinical study analyzes what interactions people have when they take Zoledronic and Aranesp. It is created by eHealthMe based on reports of 117 people who take the same drugs from the FDA, and is updated regularly.
What is Zoledronic?
Zoledronic has active ingredients of zoledronic acid. eHealthMe is studying from 29,812 Zoledronic users. Check the latest studies of Zoledronic.
What is Aranesp?
Aranesp has active ingredients of darbepoetin alfa. It is often used in anemia. eHealthMe is studying from 54,331 Aranesp users. Check the latest studies of Aranesp.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
117 people who take Zoledronic and Aranesp together, and have interactions are studied.
What are the common drug interactions of Zoledronic and Aranesp, by gender? *
What are the common drug interactions of Zoledronic and Aranesp, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Zoledronic and Aranesp?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Zoledronic (29,812 reports)
- Aranesp (54,331 reports)
Browse all drug interactions of Zoledronic and Aranesp:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Zoledronic:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Aranesp:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Zoledronic and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Aranesp and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on zoledronic acid and darbepoetin alfa (the active ingredients of Zoledronic and Aranesp, respectively), and Zoledronic and Aranesp (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Zetia cause Cerebral Atrophy? - now
- Could Pramine cause Therapeutic Response Decreased? - a second ago
- Could Probiotic cause Ovarian Cysts? - 3 seconds ago
- Drug interactions of Zetia and Glycolax - 6 seconds ago
- Drug interactions of Ticagrelor and Hygroton - 9 seconds ago
- Could Neulasta cause Intestinal Obstruction? - 14 seconds ago
- Could Dactinomycin cause Haemoglobin Decreased? - 23 seconds ago
- Could Myambutol cause Insomnia Exacerbated? - 24 seconds ago
- Could Amiodarone Hydrochloride cause Glaucoma? - 31 seconds ago
- Could Thalidomide cause Nausea And Vomiting? - 31 seconds ago